Recent publications published by researchers at the MRC WIMM.
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.
Rai L. et al, (2026), Clin Cancer Res, 32, 188 - 202
LCN2-mediated ferroptosis resistance in tissue homeostasis and early-stage tumorigenesis of the fallopian tube epithelium.
Imaeda K. et al, (2025), iScience, 28
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline.
Yang X. et al, (2025), Adv Healthc Mater, 14
mTOR-mediated p62/SQSTM1 stabilization confers a robust survival mechanism for ovarian cancer.
Tamura T. et al, (2025), Cancer Lett, 616
Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology.
Hu Y. et al, (2025), Med Image Anal, 101
The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre.
El Tawab S. et al, (2024), Transl Cancer Res, 13, 5037 - 5049
Correction: Completing a genomic characterisation of microscopic tumour samples with copy number.
Nulsen J. et al, (2024), BMC Bioinformatics, 25
Completing a genomic characterisation of microscopic tumour samples with copy number.
Nulsen J. et al, (2023), BMC Bioinformatics, 24
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.
Nistor S. et al, (2023), Transl Cancer Res, 12, 2682 - 2692
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.
Lu Z. et al, (2022), J Clin Invest, 132
Investigation of the Potential Mechanisms Underlying Nuclear F-Actin Organization in Ovarian Cancer Cells by High-Throughput Screening in Combination With Deep Learning.
Wu W. et al, (2022), Front Cell Dev Biol, 10
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer.
Javellana M. et al, (2022), Cancer Res, 82, 169 - 176
Role of immunotherapy in ovarian cancer: a narrative review
Romanchik D. et al, (2022), GYNECOLOGY AND PELVIC MEDICINE, 5
CIDER: an interpretable meta-clustering framework for single-cell RNA-seq data integration and evaluation.
Hu Z. et al, (2021), Genome Biol, 22
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.
Artibani M. et al, (2021), JCI Insight, 6
Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation.
Santana González L. et al, (2021), Dis Model Mech, 14
Promises and challenges of adoptive T-cell therapies for solid tumours.
Morotti M. et al, (2021), Br J Cancer, 124, 1759 - 1776